Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer

Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer

Molecular prognostic markers are urgently needed in order to improve therapy decisions in prostate cancer. To better understand the requirements for biomarker studies, we re-analyzed prostate cancer tissue microarray immunohistochemistry (IHC) data from 39 prognosis markers in subsets of 50 – &...

Full description

Bibliographic Details
Main Authors: Christoph Burdelski, Aleksandra Matuszewska, Martina Kluth, Christina Koop, Katharina Grupp, Stefan Steurer, Corinna Wittmer, Sarah Minner, Maria Christina Tsourlakis, Guido Sauter, Thorsten Schlomm, Ronald Simon
Format: Article
Language:English
Published: MDPI AG 2014-04-01
Series:Microarrays
Subjects:
tissue microarray
prostate cancer
tissue quality
number of samples
prognosis
marker validation
Online Access:http://www.mdpi.com/2076-3905/3/2/137

Internet

http://www.mdpi.com/2076-3905/3/2/137

Similar Items